Cart
sales@molnova.com
Delmetacin
CAS No. 16401-80-2
Delmetacin( —— )
Catalog No. M36154 CAS No. 16401-80-2
Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 114 | Get Quote |
|
| 5MG | 170 | Get Quote |
|
| 10MG | 257 | Get Quote |
|
| 25MG | 466 | Get Quote |
|
| 50MG | 626 | Get Quote |
|
| 100MG | 891 | Get Quote |
|
| 500MG | 1782 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDelmetacin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDelmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
-
DescriptionDelmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16401-80-2
-
Formula Weight293.32
-
Molecular FormulaC18H15NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(N1C=2C(C(CC(O)=O)=C1C)=CC=CC2)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FC131 TFA (606968-52...
FC131 TFA is a CXCR4 antagonist that inhibits the binding of [125I] -sdf-1 to CXCR4 with an IC50 value of 4.5 nM and has anti-hiv activity.
-
Solasodine
Solasodine is a potentially useful precursor for steroidal compounds and hormones with anticonvulsant and central nervous system depressant activities.
-
USL311
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
